Many companies are dealing with cancer research treatment but there is a specific company that has been there and it has reached a higher level it’s named Seattle Genetic. Clay Siegall is the CEO and the chief executive officer and also he is the chairman of board at the company . He is certain that the company will carry on with the new creativity and improvement in dealing with cancer therapy services. Seattle Genetics profits increased in for 5 years hence displaying the effort and hard work that Clay Siegall did.
Dr Siegall has always been motivated in helping cancer patients and taking care of them in order to make their life better. He has also been working overtime so that he can direct the company to achieve more and also research on the therapies to treat cancer patients. When he began his career he studied biomedical then he went ahead and got a Ph.D in Genetics from George Washington University. He also served in other companies as a Senior Research Investigator at Bristol-Myers Squibb Pharmaceutical Research Institute as well as a staff member at National Cancer Institute which later made him start Seattle Genetics.
Clay Siegall interest on the research technology of helping cancer patients made him devote himself in applying his expertise so that he can help cancer patients. Some of the accomplishment he made at Settle Genetics is producing the first antibody-drug conjugates whereby the drug is spreading all over the world and is able to assist cancer patients.
Dr siegall has also displayed his good supervision in the company by helping them raise $1.2 billion with these money it has enabled the company to continue with the progression of cancer treatment with the greatest inventive technology.
Because of the great work that he did made him be recognized and also he got awarded in the year 2013 at the University of Maryland as the Alumnus of the year for Math, Computer and Natural Sciences. Furthermore he was also titled as the Pacific Northwest Ernst & Young Entrepreneur of the Year in the year 2012. He also has contributed in printing new research techniques and findings.